Education
About Us
Working with TipRanks
Follow Us
Cronos Group (CRON)
NASDAQ:CRON
CRON Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.60 - $2.48
Previous Close$2.02
Volume2.24M
Average Volume (3M)1.23M
Market Cap
$766.40M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)15.7
Beta0.79
Next Earnings
Aug 07, 2025EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding385,419,000
10 Day Avg. Volume1,265,412
30 Day Avg. Volume1,230,652
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$2.19Price Target Upside9.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Financial HealthCronos Group has robust liquidity and an asset-light model which supports its operations.
Sales GrowthGrowth was strong in multiple markets, including a 57% increase in Israel and 183% in other countries.
Bears Say
Profitability UncertaintyThe timing of profitability is unclear, and the company is not expected to achieve positive adjusted EBITDA before 2026.
Regulatory ChallengesRegulatory challenges, including unclear US federal cannabis reform and changes to the Canadian Cannabis Act, are significant factors that negatively impact the stock's valuation.
Valuation PressureCronos Group's enterprise value is slightly negative, attributed to the lack of US reform and investor restrictions, which pressures the stock compared to its peers.
Cronos Group News
CRON FAQ
What was Cronos Group’s price range in the past 12 months?
Cronos Group lowest stock price was $1.60 and its highest was $2.48 in the past 12 months.
What is Cronos Group’s market cap?
Cronos Group’s market cap is $766.40M.
When is Cronos Group’s upcoming earnings report date?
Cronos Group’s upcoming earnings report date is Aug 07, 2025 which is in 6 days.
How were Cronos Group’s earnings last quarter?
Cronos Group released its earnings results on May 08, 2025. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.01.
Is Cronos Group overvalued?
According to Wall Street analysts Cronos Group’s price is currently Undervalued.
Does Cronos Group pay dividends?
Cronos Group does not currently pay dividends.
What is Cronos Group’s EPS estimate?
Cronos Group’s EPS estimate is 0.02.
How many shares outstanding does Cronos Group have?
Cronos Group has 385,419,000 shares outstanding.
What happened to Cronos Group’s price movement after its last earnings report?
Cronos Group reported an EPS of $0.02 in its last earnings report, beating expectations of $0.01. Following the earnings report the stock price went up 8.108%.
Which hedge fund is a major shareholder of Cronos Group?
Currently, no hedge funds are holding shares in CRON
Cronos Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.19 (9.50% Upside)
$2.19 (9.50% Upside)
Blogger Sentiment
Bullish
CRON Sentiment 66%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.3%
Last 30 Days ▲ 3.6%
Last 30 Days ▲ 3.6%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-17.69%
12-Months-Change
Fundamentals
Return on Equity
4.61%
Trailing 12-Months
Asset Growth
4.09%
Trailing 12-Months
Company Description
Cronos Group
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
CRON Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Cronos Group's earnings call highlighted strong revenue growth and market leadership in both domestic and international markets, notably in Israel. The company has a solid balance sheet and is undertaking strategic expansions to address supply constraints. However, challenges include potential tariffs in Israel and temporary supply constraints affecting growth. Despite these challenges, the positive aspects largely outweigh the negatives.Read More>CRON Stock 12 Month Forecast
Average Price Target
$2.19
▲(9.50%Upside)
Technical Analysis
Ownership Overview
4.08% Insiders
0.60% Mutual Funds
― Other Institutional Investors
92.56% Public Companies and Individual Investors